全文获取类型
收费全文 | 4160篇 |
免费 | 184篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 16篇 |
妇产科学 | 85篇 |
基础医学 | 173篇 |
口腔科学 | 26篇 |
临床医学 | 679篇 |
内科学 | 464篇 |
皮肤病学 | 8篇 |
神经病学 | 42篇 |
特种医学 | 71篇 |
外科学 | 324篇 |
综合类 | 577篇 |
预防医学 | 770篇 |
眼科学 | 16篇 |
药学 | 418篇 |
2篇 | |
中国医学 | 396篇 |
肿瘤学 | 318篇 |
出版年
2023年 | 24篇 |
2022年 | 120篇 |
2021年 | 184篇 |
2020年 | 184篇 |
2019年 | 25篇 |
2018年 | 43篇 |
2017年 | 13篇 |
2016年 | 20篇 |
2015年 | 12篇 |
2014年 | 579篇 |
2013年 | 391篇 |
2012年 | 586篇 |
2011年 | 587篇 |
2010年 | 469篇 |
2009年 | 476篇 |
2008年 | 286篇 |
2007年 | 44篇 |
2006年 | 31篇 |
2005年 | 39篇 |
2004年 | 34篇 |
2003年 | 36篇 |
2002年 | 17篇 |
2001年 | 22篇 |
2000年 | 66篇 |
1999年 | 20篇 |
1998年 | 15篇 |
1997年 | 11篇 |
1996年 | 12篇 |
1995年 | 12篇 |
1994年 | 17篇 |
1993年 | 5篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有4393条查询结果,搜索用时 15 毫秒
31.
肝脏疾病是影响人类健康的主要问题之一。超声在肝脏弥漫性和局灶性病变诊疗中发挥着重要作用,但传统超声评估存在主观性强且提供信息有限的问题。人工智能技术因能弥补传统超声的不足而被广泛应用于肝病超声领域,其在肝脏疾病诊断、疗效评估和预后预测等领域的应用取得了显著进展。本文对近年来国内外基于超声影像的人工智能技术在肝脏弥漫性和局灶性病变诊疗中的研究进展进行综述。 相似文献
32.
随着生活水平及生活方式的改变,以肥胖为特征的代谢性心血管疾病呈逐年增加的趋势。肥胖诱导脂肪组织的病理性扩充所导致的脂肪功能紊乱和脂肪因子内分泌失调参与心血管疾病发生发展的全过程。本文旨在综述不同类型的脂肪组织及新近发现的脂肪因子在生理或病理状态下,通过内分泌或旁分泌作用,参与心血管稳态维持或心血管疾病的调节,从而为肥胖相关的代谢性心血管疾病的防治提供新思路和新靶点。 相似文献
33.
34.
《Hepatobiliary & pancreatic diseases international : HBPD INT》2022,21(6):538-542
BackgroundThe shortage of donor liver restricts liver transplantation (LT). Nowadays, donor liver with ABO blood group incompatibility between donor and recipient has become an option to expand the source of donor liver. Although it is now possible to perform ABO-incompatible (ABO-I) LT, antibody-mediated rejection (AMR) has been recognized as the primary cause of desperate outcomes after ABO-I LT. Anti-A/B antibody is the trigger of immune response to ABO-I LT graft injury. Therapeutic plasma exchange (TPE) can quickly reduce the titer of plasma antibodies and effectively inhibit humoral immunity.Data sourcesWe searched PubMed and CNKI databases using search terms “therapeutic plasma exchange”, “ABO-incompatible liver transplantation”, “ABO-I LT”, “liver transplantation”, “LT”, “antibody-mediated rejection”, and “AMR”. Additional publications were identified by a manual search of references from key articles. The relevant publications published before September 30, 2020 were included in this review.ResultsDifferent centers have made different attempts on whether to use TPE, when to use TPE and how often to use TPE. However, the control standard of lectin revision level is always controversial, the target titer varies significantly from center to center, and the standard target titer has not yet been established. TPE has several schemes to reduce antibody titers, but there is a lack of clinical trials that provide standardized procedures.ConclusionsTPE is essential for ABO-I LT. Hence, further research and clinical trials should be conducted to determine the best regimen for TPE to remove ABO antibodies and prevent AMR. 相似文献
35.
Zhen Fan Zhaoyou Tang Kangda Liu Dong Zhou Jizhen Lu Aina Yuan Huiyang Zhao 《Journal of cancer research and clinical oncology》1992,118(5):371-376
Summary Radioimmunoimaging and radioimmunotherapy with radioiodinated anti-(hepatocellular carcinoma ferritin) antibody (131I-or125I-FtAb) have been applied in patients with primary liver cancer. A total of 41 patients with surgically unresectable hepatocellular carcinoma (HCC) and receiving hepatic artery ligation and cannulation during exploratory laparotomy were treated with this regimen by intrahepatic arterial infusion. Compared with the control group, a decline of serum -fetoprotein (65.7% versus 42.9%) and shrinkage of tumor (68.3% versus 33.9%) were observed in the treated group, and a higher second-look resection rate (31.7% versus 5.1%) and longer survival (1-year: 61.0% versus 37.3%, 3-year: 25.0% versus 6.9%) resulted. The administration of antibody through a hepatic arterial catheter (n=16) was compared with intravenous injection (n-17) in terms of the tumor-imaging sensitivity in 33 patients with liver cancer. The results indicated that hepatic arterial infusion was superior to intravenous injection. The sensitivity 7 days after the administration was 100% in the i.a. group and 76.5% in the i.v. group, the uptake ratio of tumor to liver being 1.74±0.57 in the former and 1.34±0.29 in the latter. Furthermore, intrahepatic arterial infusion revealed a lower anti-antibody detection rate than intravenous injection (0/14 versus 4/11).Abbreviations AFP
-tetoprotein
- FtAb
ferritin antibody 相似文献
36.
Xin-Da Zhou Zhao-You Tang Ye-Qin Yu Jian-Mao Weng Zeng-Chen Ma Bo-Heng Zhang Ya-Xin Zheng 《Journal of cancer research and clinical oncology》1993,120(1-2):100-102
From November 1973 to June 1992, cryosurgery with liquid nitrogen (–196°C) was performed on 113 patients with hepatic cancer, including 107 patients with primary liver cancer (PLC) and 6 patients with secondary liver cancer (SLC). Of the 107 PLC patients, the subclinical stage constituted 30.8% (33/107), the moderate stage 61.7% (66/107), and the late stage 7.5% (8/107). There were 32 cases with small PLC (up to 5 cm). Liver cirrhosis was observed in 86.0% (92/107). We designed flat cryoprobes for freezing surface tumors, and single and multiple trocar cryoprobes for freezing tumors deep within the hepatic parenchyma. Intraoperative ultrasound was used for monitoring hepatic cryolesions. There were no operative mortalities and complications, such as rupture of a tumor, delayed bleeding, or bile leakage. The 5-year and 10-year survival rates were 22.0% and 8.2%, respectively, for the 107 PLC patients and 48.8% and 17.1%, respectively, for the 32 patients with small PLC. Of the 6 SLC patients, survival ranged from 2 months to 90 months (average, 23.2 months). One SLC patient has been well for 7 years and 6 months after cryosurgery. These results indicate that cryosurgery, the in situ freezing of cancer, is a safe and effective treatment for unresectable hepatic cancer.Abbreviations PLC
primary liver cancer
- SLC
secondary liver cancer
- IOUS
intraoperative ultrasound
- AFP
-fetoprotein
Presented in part at the 4th World Congress of Hepato-Pancreato-Biliary Surgery, 7–11 June 1992, Hong Kong 相似文献
37.
目的探讨透明细胞乳头状肾细胞癌(CCPRCC)的影像学表现。方法分析15例CCPRCC患者CT及MRI影像特征,采用独立样本t检验比较肿瘤与肾皮质之间平扫CT值、ADC值差异。结果15例均为单发,边界清晰,大小为(3.1±1.9)cm。13例为实性肿瘤,其中11例伴囊变,2例为囊性肿瘤。4例CT平扫呈等或稍低密度,4例呈稍高密度;6例密度不均匀,1例伴细条状钙化;8例CT值为(38.4±10.6)HU,与肾皮质比较差异无统计学意义(P>0.05)。8例MRI平扫T1WI呈稍低或低信号,3例伴发结节状、灶状高信号;8例T2WI以混杂高信号为主,5例边缘见包膜;7例DWI呈稍高信号;9例肿瘤ADC值(2.22±0.30)×10-3 mm2/s高于肾皮质,两者差异具有统计学意义(P<0.05)。增强扫描13例实性肿瘤中9例呈“快进快出”强化,4例呈持续或渐进性强化;2例囊性肿瘤增强扫描呈囊壁及中心分隔强化。结论CCPRCC好发于中老年人,肿瘤易发生囊变,出血、钙化少见,弥散受限不明显,增强扫描以“快进快出”强化为主,确诊仍需依靠组织病理学。 相似文献
38.
39.
目的通过比较膝关节骨性关节炎(OA)病人定量动态负荷前后膝关节软骨T2时间变化情况,分析MRIT2mapping序列反映软骨基质生物力学变化的灵敏度.并验证高磁场条件下人体关节负荷装置的有效性。方法10例膝关节OA病人,其中男性3例.女性7例:年龄4l~66岁.平均年龄57-3岁。依托人体下肢关节力学负荷装置,对其施加膝关节动态负荷。负荷前后行膝关节MRIT2maDping成像,将膝关节轴向负荷区软骨分为4个部位:胫骨平台内、外侧软骨区及股骨内、外侧髁软骨区.分别测量各部位软骨负荷前后的T,时间。对负荷前膝关节内、外侧软骨分级评估进行卡方检验,对同一软骨区动态负荷前后的T2时间进行配对t检验。结果负荷前膝关节内外侧软骨分级差异无统计学意义(P〉0.05)。OA病人负荷前后T2值,胫骨平台内侧软骨区分别为(39.59±4.17)ms、(40.14±4.49)ms(f=0.426,P=0.680);胫骨平台外侧软骨区(38.85±6.72)ms、(41.25±6.54)ms(t=1.704,P=0.123):股骨内侧髁软骨区(36.44±5.72)ms、(40.63±4.90)ms(t=1.783,P=0.108);股骨外侧髁软骨区(39.30±5.78)ms、(46.14±5.03)ms(t=2.826,P=0.020)。结论OA病人负荷后膝关节局部区域软骨区T2时间延长.自行设计的动态加压装置适合在高磁场条件下完成加压及MRI检查,有一定推广意义。 相似文献
40.
阐述时间管理倾向的概念,从护理人员时间管理倾向的现状、护理人员主观幸福感及两者之间的关系等方面进行综述,旨在了解护理人员时间管理倾向与幸福感关系的现状,以期能制定出更适合护理人员的时间管理机制,提高护理人员的主观幸福感,从而提高护理质量。 相似文献